NOVAVITA THERA

gene therapies, namely, in vivo and ex vivo vector treatments; lentiviral vector therapies; gene therapies for the treatment of rare diseases; gene th Read More

Classification Information

Class [5]
Pharmaceutical Products

Gene therapies, namely, in vivo and ex vivo vector treatments; lentiviral vector therapies; gene therapies for the treatment of rare diseases; gene therapies for Hereditary Tyrosinemia Type 1; gene therapies for orphan disease; therapies for inborn errors of hepatic metabolism.

Mark Details

Serial Number

UK00003629906

Mark Type

Word

Kind of mark

Individual